Symbols / INO Stock $1.41 -1.40% Inovio Pharmaceuticals, Inc.
INO (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
No company description available for this symbol.
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest INO news- INO Stock Grinds Higher As Traders Eye Q1 2026 Catalyst - StocksToTrade Fri, 08 May 2026 20
- Two INOVIO studies head to May medical meetings in Boston, Chicago - Stock Titan Fri, 08 May 2026 12
- INO, MRNA, NVAX, EBS Jump Overnight: Trump Promises Full Hantavirus Report As Deadly Outbreak Sparks Vaccine Rally - Stocktwits Fri, 08 May 2026 05
- INO Stock Jumps As Inovio Showcases DNA Medicine Data - timothysykes.com Sun, 10 May 2026 14
- Is Inovio (INO) Turning Fresh DNA Medicine Data Into a More Coherent Investment Story? - simplywall.st Sun, 10 May 2026 10
- INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - PR Newswire hu, 12 Mar 2026 07
- Inovio Pharmaceuticals stock (US45773H2013): Earnings preview and DNA?medicine pipeline in focus - AD HOC NEWS Fri, 08 May 2026 21
- Inovio Pharmaceuticals, Inc. (INO) Presents at World Federation of Hemophilia World Congress - Slideshow - Seeking Alpha Fri, 24 Apr 2026 07
- INO Stock Soars as FDA Backs Rolling BLA for Rare Lung Disease Drug - Yahoo Finance hu, 28 Aug 2025 07
- INO Stock Steadies Ahead Of Q1 2026 Earnings Catalyst - timothysykes.com Fri, 08 May 2026 20
- INOVIO to discuss Q1 results and business update in May 13 webcast - Stock Titan Fri, 01 May 2026 07
- MRNA, INO, SABS, NVAX Stocks Jump Premarket: Deadly Hantavirus Reaches US After Cruise Ship Outbreak - Stocktwits Mon, 11 May 2026 08
- INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights - PR Newswire Mon, 10 Nov 2025 08
- Inovio Pharmaceuticals stock (US45773H2013): Hantavirus research sparks investor interest - AD HOC NEWS ue, 12 May 2026 17
- Inovio Pharmaceuticals, Inc. Stock Alert: INO Stockholders Who Lost Money in the Company Should Contact Robbins LLP for Information on How to Recover Their Losses - PR Newswire hu, 26 Feb 2026 08
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.07
-69.99%
|
0.22
-73.83%
|
0.83
-91.89%
|
10.26
|
| Operating Revenue |
|
0.07
-69.99%
|
0.22
-73.83%
|
0.83
-91.89%
|
10.26
|
| Operating Expense |
|
86.89
-22.85%
|
112.62
-16.12%
|
134.26
-51.68%
|
277.84
|
| Research And Development |
|
54.21
-28.32%
|
75.62
-12.76%
|
86.68
-53.81%
|
187.65
|
| Selling General And Administration |
|
32.68
-11.67%
|
37.00
-22.25%
|
47.58
-47.24%
|
90.19
|
| General And Administrative Expense |
|
32.68
-11.67%
|
37.00
-22.25%
|
47.58
-47.24%
|
90.19
|
| Other Gand A |
|
32.68
-11.67%
|
37.00
-22.25%
|
47.58
-47.24%
|
90.19
|
| Total Expenses |
|
86.89
-22.85%
|
112.62
-16.12%
|
134.26
-51.68%
|
277.84
|
| Operating Income |
|
-86.82
+22.76%
|
-112.40
+15.76%
|
-133.43
+50.13%
|
-267.57
|
| Total Operating Income As Reported |
|
-86.82
+22.76%
|
-112.40
+21.91%
|
-143.94
+46.21%
|
-267.57
|
| EBITDA |
|
-81.96
+21.15%
|
-103.95
+20.28%
|
-130.39
+51.87%
|
-270.90
|
| Normalized EBITDA |
|
-83.57
+23.22%
|
-108.83
+13.44%
|
-125.73
+52.20%
|
-263.06
|
| Reconciled Depreciation |
|
2.99
-4.51%
|
3.13
-10.66%
|
3.50
-36.25%
|
5.50
|
| EBIT |
|
-84.95
+20.67%
|
-107.08
+20.03%
|
-133.89
+51.56%
|
-276.40
|
| Total Unusual Items |
|
1.61
-67.09%
|
4.89
+204.78%
|
-4.66
+40.57%
|
-7.85
|
| Total Unusual Items Excluding Goodwill |
|
1.61
-67.09%
|
4.89
+204.78%
|
-4.66
+40.57%
|
-7.85
|
| Special Income Charges |
|
—
|
0.00
+100.00%
|
-10.51
|
0.00
|
| Impairment Of Capital Assets |
|
—
|
0.00
-100.00%
|
10.51
|
0.00
|
| Net Income |
|
-84.95
+20.80%
|
-107.25
+20.62%
|
-135.12
+51.71%
|
-279.82
|
| Pretax Income |
|
-84.95
+20.80%
|
-107.25
+20.62%
|
-135.12
+51.34%
|
-277.65
|
| Net Non Operating Interest Income Expense |
|
2.42
-47.26%
|
4.59
-33.59%
|
6.91
+95.87%
|
3.53
|
| Interest Expense Non Operating |
|
0.00
-100.00%
|
0.18
-85.46%
|
1.22
-2.49%
|
1.25
|
| Net Interest Income |
|
2.42
-47.26%
|
4.59
-33.59%
|
6.91
+95.87%
|
3.53
|
| Interest Expense |
|
0.00
-100.00%
|
0.18
-85.46%
|
1.22
-2.49%
|
1.25
|
| Interest Income Non Operating |
|
2.42
-49.23%
|
4.77
-41.39%
|
8.13
+70.08%
|
4.78
|
| Interest Income |
|
2.42
-49.23%
|
4.77
-41.39%
|
8.13
+70.08%
|
4.78
|
| Other Income Expense |
|
-0.54
-197.90%
|
0.56
+106.46%
|
-8.60
+36.79%
|
-13.61
|
| Other Non Operating Income Expenses |
|
-2.64
+16.50%
|
-3.16
+32.85%
|
-4.71
-22.01%
|
-3.86
|
| Gain On Sale Of Security |
|
1.61
-67.09%
|
4.89
-16.49%
|
5.85
+174.57%
|
-7.85
|
| Tax Provision |
|
—
|
—
|
—
|
—
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-84.95
+20.80%
|
-107.25
+20.62%
|
-135.12
+51.71%
|
-279.82
|
| Net Income From Continuing Operation Net Minority Interest |
|
-84.95
+20.80%
|
-107.25
+20.62%
|
-135.12
+51.71%
|
-279.82
|
| Net Income From Continuing And Discontinued Operation |
|
-84.95
+20.80%
|
-107.25
+20.62%
|
-135.12
+51.71%
|
-279.82
|
| Net Income Continuous Operations |
|
-84.95
+20.80%
|
-107.25
+20.62%
|
-135.12
+51.71%
|
-279.82
|
| Minority Interests |
|
—
|
—
|
—
|
0.00
|
| Normalized Income |
|
-86.55
+22.82%
|
-112.14
+14.04%
|
-130.45
+52.03%
|
-271.97
|
| Net Income Common Stockholders |
|
-84.95
+20.80%
|
-107.25
+20.62%
|
-135.12
+51.71%
|
-279.82
|
| Diluted EPS |
|
-1.81
+54.18%
|
-3.95
+35.14%
|
-6.09
+56.62%
|
-14.04
|
| Basic EPS |
|
-1.81
+54.18%
|
-3.95
+35.14%
|
-6.09
+56.62%
|
-14.04
|
| Basic Average Shares |
|
46.89
+72.62%
|
27.16
+22.49%
|
22.17
+11.51%
|
19.89
|
| Diluted Average Shares |
|
46.89
+72.62%
|
27.16
+22.49%
|
22.17
+11.51%
|
19.89
|
| Diluted NI Availto Com Stockholders |
|
-84.95
+20.80%
|
-107.25
+20.62%
|
-135.12
+51.71%
|
-279.82
|
| Earnings From Equity Interest |
|
0.49
+141.99%
|
-1.17
-250.87%
|
0.77
+140.70%
|
-1.90
|
| Earnings From Equity Interest Net Of Tax |
|
—
|
—
|
0.00
+100.00%
|
-2.17
|
| Line Item | Trend | 2023-12-31 |
|---|---|---|
| Total Assets |
|
170.95
|
| Current Assets |
|
153.11
|
| Cash Cash Equivalents And Short Term Investments |
|
145.29
|
| Cash And Cash Equivalents |
|
14.31
|
| Other Short Term Investments |
|
130.98
|
| Receivables |
|
2.41
|
| Accounts Receivable |
|
2.41
|
| Prepaid Assets |
|
5.41
|
| Restricted Cash |
|
0.00
|
| Other Current Assets |
|
0.02
|
| Total Non Current Assets |
|
17.84
|
| Net PPE |
|
14.45
|
| Gross PPE |
|
35.30
|
| Accumulated Depreciation |
|
-20.85
|
| Properties |
|
0.00
|
| Machinery Furniture Equipment |
|
6.36
|
| Other Properties |
|
13.03
|
| Leases |
|
15.92
|
| Goodwill And Other Intangible Assets |
|
0.00
|
| Goodwill |
|
0.00
|
| Other Intangible Assets |
|
—
|
| Investments And Advances |
|
2.78
|
| Long Term Equity Investment |
|
2.78
|
| Other Non Current Assets |
|
0.61
|
| Total Liabilities Net Minority Interest |
|
53.60
|
| Current Liabilities |
|
42.57
|
| Payables And Accrued Expenses |
|
13.45
|
| Payables |
|
4.65
|
| Accounts Payable |
|
4.65
|
| Current Accrued Expenses |
|
8.80
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
9.84
|
| Current Debt And Capital Lease Obligation |
|
19.18
|
| Current Debt |
|
16.77
|
| Other Current Borrowings |
|
16.77
|
| Current Capital Lease Obligation |
|
2.41
|
| Current Deferred Liabilities |
|
—
|
| Current Deferred Revenue |
|
—
|
| Other Current Liabilities |
|
0.11
|
| Total Non Current Liabilities Net Minority Interest |
|
11.03
|
| Long Term Debt And Capital Lease Obligation |
|
11.03
|
| Long Term Debt |
|
—
|
| Long Term Capital Lease Obligation |
|
11.03
|
| Non Current Deferred Liabilities |
|
0.00
|
| Non Current Deferred Revenue |
|
—
|
| Non Current Deferred Taxes Liabilities |
|
0.00
|
| Other Non Current Liabilities |
|
—
|
| Stockholders Equity |
|
117.35
|
| Common Stock Equity |
|
117.35
|
| Capital Stock |
|
0.02
|
| Common Stock |
|
0.02
|
| Preferred Stock |
|
0.00
|
| Share Issued |
|
22.79
|
| Ordinary Shares Number |
|
22.79
|
| Treasury Shares Number |
|
0.00
|
| Additional Paid In Capital |
|
1,740.95
|
| Retained Earnings |
|
-1,622.97
|
| Gains Losses Not Affecting Retained Earnings |
|
-0.66
|
| Other Equity Adjustments |
|
-0.66
|
| Total Equity Gross Minority Interest |
|
117.35
|
| Total Capitalization |
|
117.35
|
| Working Capital |
|
110.54
|
| Invested Capital |
|
134.12
|
| Total Debt |
|
30.21
|
| Net Debt |
|
2.46
|
| Capital Lease Obligations |
|
13.44
|
| Net Tangible Assets |
|
117.35
|
| Tangible Book Value |
|
117.35
|
| Duefrom Related Parties Current |
|
2.41
|
| Investmentsin Associatesat Cost |
|
—
|
| Investmentsin Subsidiariesat Cost |
|
—
|
| Preferred Shares Number |
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-88.63
+14.84%
|
-104.08
+16.31%
|
-124.37
+42.48%
|
-216.22
|
| Cash Flow From Continuing Operating Activities |
|
-88.63
+14.84%
|
-104.08
+16.31%
|
-124.37
+42.48%
|
-216.22
|
| Net Income From Continuing Operations |
|
-84.95
+20.80%
|
-107.25
+20.62%
|
-135.12
+51.71%
|
-279.82
|
| Depreciation Amortization Depletion |
|
2.99
-4.51%
|
3.13
-10.66%
|
3.50
-36.25%
|
5.50
|
| Depreciation |
|
2.99
-4.51%
|
3.13
-6.79%
|
3.36
-32.83%
|
5.00
|
| Amortization Cash Flow |
|
—
|
0.00
-100.00%
|
0.15
-70.71%
|
0.50
|
| Depreciation And Amortization |
|
2.99
-4.51%
|
3.13
-10.66%
|
3.50
-36.25%
|
5.50
|
| Amortization Of Intangibles |
|
—
|
0.00
-100.00%
|
0.15
-70.71%
|
0.50
|
| Other Non Cash Items |
|
—
|
-0.36
-328.26%
|
0.16
-16.67%
|
0.19
|
| Stock Based Compensation |
|
3.76
-43.05%
|
6.60
-40.44%
|
11.07
-50.91%
|
22.56
|
| Asset Impairment Charge |
|
—
|
0.00
-100.00%
|
12.50
|
0.00
|
| Deferred Tax |
|
—
|
0.00
+100.00%
|
-0.03
|
0.00
|
| Deferred Income Tax |
|
—
|
0.00
+100.00%
|
-0.03
|
0.00
|
| Operating Gains Losses |
|
-0.09
-138.28%
|
0.24
-94.47%
|
4.35
-51.68%
|
9.00
|
| Gain Loss On Investment Securities |
|
0.40
+144.03%
|
-0.90
-118.79%
|
4.81
+19.25%
|
4.03
|
| Unrealized Gain Loss On Investment Securities |
|
-1.11
+46.33%
|
-2.08
+64.50%
|
-5.85
-174.57%
|
7.85
|
| Net Foreign Currency Exchange Gain Loss |
|
—
|
—
|
—
|
—
|
| Gain Loss On Sale Of PPE |
|
0.00
+100.00%
|
-0.02
-107.06%
|
0.32
-70.41%
|
1.07
|
| Change In Working Capital |
|
-9.22
-245.93%
|
-2.66
+74.03%
|
-10.26
-151.73%
|
19.83
|
| Change In Receivables |
|
—
|
1.21
-87.08%
|
9.33
+351.82%
|
-3.71
|
| Changes In Account Receivables |
|
—
|
1.21
-87.08%
|
9.33
+351.82%
|
-3.71
|
| Change In Prepaid Assets |
|
1.11
-58.89%
|
2.69
-93.11%
|
39.02
+831.20%
|
-5.34
|
| Change In Payables And Accrued Expense |
|
-7.79
-104.04%
|
-3.82
+92.95%
|
-54.22
-264.92%
|
32.87
|
| Change In Accrued Expense |
|
-1.37
-299.15%
|
-0.34
+95.83%
|
-8.23
-3172.62%
|
0.27
|
| Change In Payable |
|
-6.42
-84.76%
|
-3.48
+92.44%
|
-45.99
-241.04%
|
32.61
|
| Change In Account Payable |
|
-6.42
-84.76%
|
-3.48
+92.44%
|
-45.99
-241.04%
|
32.61
|
| Change In Other Working Capital |
|
-2.50
-58.72%
|
-1.57
+22.15%
|
-2.02
+24.87%
|
-2.69
|
| Change In Other Current Assets |
|
-0.03
-184.37%
|
0.04
-50.59%
|
0.08
-89.39%
|
0.74
|
| Change In Other Current Liabilities |
|
—
|
-0.11
+95.54%
|
-2.45
-19.71%
|
-2.05
|
| Investing Cash Flow |
|
14.04
-86.51%
|
104.07
+19.13%
|
87.36
-20.29%
|
109.59
|
| Cash Flow From Continuing Investing Activities |
|
14.04
-86.51%
|
104.07
+19.13%
|
87.36
-20.29%
|
109.59
|
| Net PPE Purchase And Sale |
|
-0.29
+33.33%
|
-0.43
-107.26%
|
5.90
+708.61%
|
-0.97
|
| Purchase Of PPE |
|
-0.29
+41.44%
|
-0.49
-52.02%
|
-0.32
+66.89%
|
-0.97
|
| Sale Of PPE |
|
0.00
-100.00%
|
0.06
-99.05%
|
6.22
|
0.00
|
| Capital Expenditure |
|
-0.29
+41.44%
|
-0.49
-52.02%
|
-0.32
+66.89%
|
-0.97
|
| Capital Expenditure Reported |
|
—
|
—
|
—
|
—
|
| Net Investment Purchase And Sale |
|
14.33
-86.29%
|
104.50
+28.29%
|
81.46
-27.63%
|
112.56
|
| Purchase Of Investment |
|
-4.95
+90.86%
|
-54.14
+73.39%
|
-203.48
+18.13%
|
-248.53
|
| Sale Of Investment |
|
19.27
-87.85%
|
158.64
-44.32%
|
284.93
-21.09%
|
361.08
|
| Net Business Purchase And Sale |
|
—
|
—
|
0.00
+100.00%
|
-2.00
|
| Purchase Of Business |
|
—
|
—
|
0.00
+100.00%
|
-2.00
|
| Gain Loss On Sale Of Business |
|
—
|
—
|
—
|
0.00
|
| Financing Cash Flow |
|
53.05
+3.06%
|
51.48
+930.52%
|
5.00
-93.90%
|
81.84
|
| Cash Flow From Continuing Financing Activities |
|
53.05
+3.06%
|
51.48
+930.52%
|
5.00
-93.90%
|
81.84
|
| Net Issuance Payments Of Debt |
|
0.00
+100.00%
|
-16.41
|
0.00
|
0.00
|
| Issuance Of Debt |
|
—
|
—
|
—
|
0.00
|
| Repayment Of Debt |
|
0.00
+100.00%
|
-16.41
|
0.00
|
—
|
| Long Term Debt Issuance |
|
—
|
—
|
—
|
0.00
|
| Net Long Term Debt Issuance |
|
—
|
—
|
—
|
0.00
|
| Short Term Debt Payments |
|
0.00
+100.00%
|
-16.41
|
0.00
|
—
|
| Net Short Term Debt Issuance |
|
0.00
+100.00%
|
-16.41
|
0.00
|
—
|
| Net Common Stock Issuance |
|
34.91
-3.12%
|
36.03
+559.74%
|
5.46
-93.42%
|
82.96
|
| Proceeds From Stock Option Exercised |
|
18.25
-43.45%
|
32.28
|
0.00
-100.00%
|
0.28
|
| Net Other Financing Charges |
|
-0.11
+73.67%
|
-0.42
+9.83%
|
-0.47
+66.61%
|
-1.40
|
| Changes In Cash |
|
-21.54
-141.85%
|
51.47
+260.77%
|
-32.01
-29.15%
|
-24.79
|
| Effect Of Exchange Rate Changes |
|
0.00
-100.00%
|
0.03
+926.61%
|
-0.00
+84.66%
|
-0.03
|
| Beginning Cash Position |
|
65.81
+359.88%
|
14.31
-69.11%
|
46.33
-34.88%
|
71.14
|
| End Cash Position |
|
44.27
-32.73%
|
65.81
+359.88%
|
14.31
-69.11%
|
46.33
|
| Free Cash Flow |
|
-88.92
+14.97%
|
-104.56
+16.14%
|
-124.69
+42.59%
|
-217.18
|
| Interest Paid Supplemental Data |
|
0.00
-100.00%
|
0.53
-50.00%
|
1.07
+0.00%
|
1.07
|
| Income Tax Paid Supplemental Data |
|
—
|
—
|
—
|
1.07
|
| Amortization Of Securities |
|
-0.00
+99.86%
|
-1.69
+63.92%
|
-4.69
-254.86%
|
-1.32
|
| Common Stock Issuance |
|
34.91
-3.12%
|
36.03
+559.74%
|
5.46
-93.42%
|
82.96
|
| Earnings Losses From Equity Investments |
|
-0.49
-141.99%
|
1.17
+250.87%
|
-0.77
-119.83%
|
3.90
|
| Issuance Of Capital Stock |
|
34.91
-3.12%
|
36.03
+559.74%
|
5.46
-93.42%
|
82.96
|
| Sale Of Business |
|
—
|
—
|
—
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-04-06 View
- 8-K2026-04-02 View
- 42026-04-01 View
- 8-K2026-03-12 View
- 10-K2026-03-12 View
- 42026-03-05 View
- 42026-03-05 View
- 42026-03-05 View
- 42026-03-05 View
- 42026-02-27 View
- 42026-02-27 View
- 42026-02-27 View
- 42026-02-27 View
- 42026-02-27 View
- 8-K2026-01-27 View
- 8-K2025-12-29 View
- 8-K2025-11-12 View
- 8-K2025-11-10 View
- 10-Q2025-11-10 View
- 8-K2025-08-12 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|